In this report, we show that a small molecule called MCB-613 elicits opposite effects on p53-WT and p53-R175H mutant protein levels in ovarian cancer cells, and that these effects of MCB-613 on p53 turnover are independent of its role as a pan-SRC “super” stimulator21. Here, SRC is linked to ovarian carcinoma.